Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00732641 · BASELINE

Baseline characteristics

Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7) · Source last updated 2017-04-04

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      122
    2. group Id
      BG001
      value
      121
    3. group Id
      BG002
      value
      243
    units
    Participants
groups
  1. description
    Peginterferon α-2b 35 μg, weekly, subcutaneous (SC), until disease progression or relapse, or for up to a maximum of 5 years.
    id
    BG000
    title
    Peginterferon α-2b
  2. description
    Participants were observed and received no treatment
    id
    BG001
    title
    No Treatment
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.5
          value
          61.0
        2. group Id
          BG001
          spread
          8.6
          value
          62.3
        3. group Id
          BG002
          spread
          8.6
          value
          61.7
    description
    Age was for the intent-to-treat population (those who received at least one dose of study drug)
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          53
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          113
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          69
        2. group Id
          BG001
          value
          61
        3. group Id
          BG002
          value
          130
        title
        Male
    description
    Gender was for the intent-to-treat population (those who received at least one dose of study drug)
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          123
        2. group Id
          BG001
          value
          121
        3. group Id
          BG002
          value
          244
      title
      Italy
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      122
    2. group Id
      BG001
      value
      121
    3. group Id
      BG002
      value
      243
    units
    Participants
groups
  1. description
    Peginterferon α-2b 35 μg, weekly, subcutaneous (SC), until disease progression or relapse, or for up to a maximum of 5 years.
    id
    BG000
    title
    Peginterferon α-2b
  2. description
    Participants were observed and received no treatment
    id
    BG001
    title
    No Treatment
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          8.5
          value
          61.0
        2. group Id
          BG001
          spread
          8.6
          value
          62.3
        3. group Id
          BG002
          spread
          8.6
          value
          61.7
    description
    Age was for the intent-to-treat population (those who received at least one dose of study drug)
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          53
        2. group Id
          BG001
          value
          60
        3. group Id
          BG002
          value
          113
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          69
        2. group Id
          BG001
          value
          61
        3. group Id
          BG002
          value
          130
        title
        Male
    description
    Gender was for the intent-to-treat population (those who received at least one dose of study drug)
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          123
        2. group Id
          BG001
          value
          121
        3. group Id
          BG002
          value
          244
      title
      Italy
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice